Page 1 of Clinical Trials for Pathologic Complete Response, 821 Total Matches
- 1Active, not recruitingLast Updated: July 1, 2011Condition(s): Invasive Breast Cancer
- 2RecruitingLast Updated: May 23, 2011Condition(s): ErbB2-Positive Stage I-III Breast Cancer
- 3Active, not recruitingLast Updated: November 21, 2010Condition(s): Breast Cancer
- 4RecruitingLast Updated: April 21, 2011Condition(s): HER-2 Positive Breast Cancer
- 5RecruitingLast Updated: December 7, 2011Condition(s): Metastatic Breast Cancer
- 6RecruitingLast Updated: February 1, 2012Condition(s): Breast Cancer
- 7Active, not recruitingLast Updated: January 28, 2012Condition(s): Breast Cancer
- 8CompletedLast Updated: November 2, 2011Condition(s): Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Progesterone Receptor-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer
- 9RecruitingLast Updated: September 8, 2011Condition(s): Stage II Breast Cancer; Stage III Breast Cancer
- 10RecruitingLast Updated: July 26, 2011Condition(s): Rectal Cancer
- 11RecruitingLast Updated: December 21, 2011Condition(s): Breast Neoplasms; Breast Cancer; Breast Tumors
- 12Active, not recruitingLast Updated: January 17, 2012Condition(s): Breast Cancer
- 13RecruitingLast Updated: January 6, 2012Condition(s): Rectal Neoplasms
- 14CompletedLast Updated: June 3, 2008Condition(s): Breast Cancer
- 15RecruitingLast Updated: December 8, 2011Condition(s): Triple Negative Breast Cancer
- 16TerminatedLast Updated: August 15, 2011Condition(s): Esophageal Cancer
- 17Active, not recruitingLast Updated: February 2, 2012Condition(s): Neoplasms, Breast; Breast Cancer
- 18RecruitingLast Updated: April 7, 2011Condition(s): Breast Cancer
- 19CompletedLast Updated: October 4, 2011Condition(s): Breast Cancer
- 20CompletedLast Updated: March 24, 2010Condition(s): Breast Neoplasms
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Pathologic+Complete+Response
